Breaking News Instant updates and real-time market news.

SFTBF

SoftBank

$0.00

(0.00%)

, HLI

Houlihan Lokey

$46.33

1.12 (2.48%)

14:39
10/15/19
10/15
14:39
10/15/19
14:39

SoftBank hires Houlihan Lokey over WeWork cash crunch, Bloomberg says

SoftBank (SFTBF) has hired investment bankers at Houlihan Lokey (HLI) to look into options for easing WeWork's (WE) cash crunch, Bloomberg's Gillian Tan, Liana Baker, and Nabila Ahmed report, citing people with knowledge of the discussions. Houlihan is working on slashing liabilities as WeWork considers a separate deal that could give control of the company to SoftBank, the authors note. Reference Link

SFTBF

SoftBank

$0.00

(0.00%)

HLI

Houlihan Lokey

$46.33

1.12 (2.48%)

WE

We Company

$0.00

(0.00%)

  • 24

    Oct

SFTBF SoftBank
$0.00

(0.00%)

12/12/18
RBCM
12/12/18
NO CHANGE
Target $230
RBCM
Outperform
Nvidia price target lowered to $230 from $260 at RBC Capital
RBC Capital analyst Mitch Steves lowered his price target on Nvidia (NVDA) to $230 after yesterday's report that Softbank (SFTBF) is exploring the sale of its stake in the company early next year. The analyst believes that in the near-term, the speculation is a negative since Softbank has "solid information on overall Data Center trends". Steves maintains his Outperform rating however, stating that a number of long-only investment managers have not participated in the run-up of the stock price. The analyst adds that Nvidia's long-term investment story around "AI/VR/AR/Autonomous" driving remains intact.
02/28/19
BTIG
02/28/19
NO CHANGE
Target $60
BTIG
Buy
SoftBank price target raised to $60 from $50 at BTIG
BTIG analyst Walter Piecyk raised his price target on SoftBank (SFTBY) to $60 and kept his Buy rating, citing his "better understanding" of the previously acquired ARM Holdings business which warrants a higher multiple. The analyst also sees a major catalyst coming in the "imminent decision" around Sprint (S) / T-Mobile (TMUS) deal, which could amount to additional $14 price target impact on Softbank shares.
HLI Houlihan Lokey
$46.33

1.12 (2.48%)

04/03/19
GSCO
04/03/19
UPGRADE
Target $52
GSCO
Buy
Houlihan Lokey upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Richard Ramsden upgraded Houlihan Lokey to Buy from Neutral and raised his price target for the shares to $52 from $44. The analyst says the cycle for the company shifting from strategic acquisitions to restructuring and financial sponsors.
04/03/19
GSCO
04/03/19
UPGRADE
Target $52
GSCO
Buy
Goldman upgrades Houlihan Lokey to Buy, says best play during downturn
Goldman Sachs analyst Richard Ramsden upgraded Houlihan Lokey to Buy from Neutral and raised his price target for the shares to $52 from $44. Houlihan Lokey is best positioned of the Americas Advisors to benefit from a shift to higher restructuring and financial sponsor activity as the strategic acquisition market slows, especially outside of the United States, Ramsden tells investors in a research note. He believes the company should exhibit higher revenue stability than peers during a downturn. Further, the analyst sees long-term growth prospects from expanding Houlihan Lokey's financing advisory and international businesses.
05/23/19
JMPS
05/23/19
DOWNGRADE
JMPS
Market Perform
Houlihan Lokey downgraded to Market Perform from Outperform at JMP Securities
05/23/19
JMPS
05/23/19
DOWNGRADE
JMPS
Market Perform
Houlihan Lokey downgraded to Market Perform at JMP Securities
As previously reported, JMP Securities analyst Devin Ryan downgraded Houlihan Lokey (HLI) to Market Perform from Outperform after having hosted a series of meetings with senior management and investment banking heads from a number of public advisory firms. Several companies that were involved in the firm's "Independent Advisory Day" started the year with a softer quarter, but Ryan said he believes each clearly feels "pretty good" about the current state of the advisory market. The analyst also upgraded Evercore Partners (EVR) to Outperform from Market Perform following the firm's "Independent Advisory Day."
WE We Company
$0.00

(0.00%)

09/10/19
09/10/19
NO CHANGE

We Company IPO is 'full speed ahead,' CNBC reports
The initial public offering of We Company is moving "full speed ahead" despite reports of the valuation reductions, CNBC's David Faber reports, citing sources close to the situation.

TODAY'S FREE FLY STORIES

AMRN

Amarin

$21.49

0.55 (2.63%)

07:00
11/14/19
11/14
07:00
11/14/19
07:00
Hot Stocks
Amarin announces Nasdaq halts trading of company's shares »

Amarin announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

GOOS

Canada Goose

$34.81

-4.245 (-10.87%)

06:59
11/14/19
11/14
06:59
11/14/19
06:59
Recommendations
Canada Goose analyst commentary  »

Canada Goose price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBIV

VBI Vaccines

$0.56

-0.0091 (-1.60%)

06:58
11/14/19
11/14
06:58
11/14/19
06:58
Initiation
VBI Vaccines initiated  »

VBI Vaccines initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$23.78

0.34 (1.45%)

06:57
11/14/19
11/14
06:57
11/14/19
06:57
Upgrade
Meritor rating change  »

Meritor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIN

Linde plc

$207.61

1.815 (0.88%)

06:57
11/14/19
11/14
06:57
11/14/19
06:57
Recommendations
Linde plc analyst commentary  »

Linde plc price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$84.76

0.63 (0.75%)

, AZN

AstraZeneca

$47.84

0.76 (1.61%)

06:56
11/14/19
11/14
06:56
11/14/19
06:56
Hot Stocks
Merck, AstraZeneca: FDA accepts NDA, grants priority review for selumetinib »

AstraZeneca (AZN) and…

MRK

Merck

$84.76

0.63 (0.75%)

AZN

AstraZeneca

$47.84

0.76 (1.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

  • 10

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

XCUR

Exicure

$2.45

-0.14 (-5.41%)

06:56
11/14/19
11/14
06:56
11/14/19
06:56
Hot Stocks
Breaking Hot Stocks news story on Exicure »

Exicure Inc trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$21.49

0.55 (2.63%)

06:55
11/14/19
11/14
06:55
11/14/19
06:55
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

XLNX

Xilinx

$93.33

-1.85 (-1.94%)

06:54
11/14/19
11/14
06:54
11/14/19
06:54
Conference/Events
Xilinx management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 20

    Nov

  • 06

    Jan

  • 28

    Jan

VCEL

Vericel

$18.80

-0.41 (-2.13%)

06:52
11/14/19
11/14
06:52
11/14/19
06:52
Conference/Events
Vericel management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ECOR

electroCore

$1.88

0.06 (3.30%)

06:51
11/14/19
11/14
06:51
11/14/19
06:51
Recommendations
electroCore analyst commentary  »

electroCore price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$66.03

-0.76 (-1.14%)

06:50
11/14/19
11/14
06:50
11/14/19
06:50
Conference/Events
UMB Financial management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

NVDA

Nvidia

$208.55

-1 (-0.48%)

06:50
11/14/19
11/14
06:50
11/14/19
06:50
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

UBX

Unity Biotechnology

$6.56

-0.21 (-3.10%)

06:49
11/14/19
11/14
06:49
11/14/19
06:49
Conference/Events
Unity Biotechnology management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 13

    Dec

TRGP

Targa Resources

$38.31

-0.5 (-1.29%)

06:47
11/14/19
11/14
06:47
11/14/19
06:47
Conference/Events
Targa Resources management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

SACH

Sachem Capital

$4.26

-0.04 (-0.93%)

06:46
11/14/19
11/14
06:46
11/14/19
06:46
Initiation
Sachem Capital initiated  »

Sachem Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCOM

Trip.com Group

$32.74

-1.03 (-3.05%)

06:46
11/14/19
11/14
06:46
11/14/19
06:46
Recommendations
Trip.com Group analyst commentary  »

Trip.com Group should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STIM

Neuronetics

$4.44

-0.39 (-8.07%)

06:44
11/14/19
11/14
06:44
11/14/19
06:44
Conference/Events
Neuronetics management to meet with BTIG »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

NTAP

NetApp

$60.04

-0.08 (-0.13%)

06:44
11/14/19
11/14
06:44
11/14/19
06:44
Recommendations
NetApp analyst commentary  »

NetApp price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 12

    Dec

SBH

Sally Beauty

$19.50

-0.45 (-2.26%)

06:43
11/14/19
11/14
06:43
11/14/19
06:43
Downgrade
Sally Beauty rating change  »

Sally Beauty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

SRNE

Sorrento Therapeutics

$1.58

-0.025 (-1.56%)

06:43
11/14/19
11/14
06:43
11/14/19
06:43
Conference/Events
Sorrento Therapeutics management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

PING

Ping Identity

$16.50

-0.25 (-1.49%)

06:42
11/14/19
11/14
06:42
11/14/19
06:42
Recommendations
Ping Identity analyst commentary  »

Ping Identity price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CACC

Credit Acceptance

$430.08

-3.57 (-0.82%)

06:40
11/14/19
11/14
06:40
11/14/19
06:40
Recommendations
Credit Acceptance analyst commentary  »

Credit Acceptance price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$18.52

-0.69 (-3.59%)

06:39
11/14/19
11/14
06:39
11/14/19
06:39
Earnings
Canopy Growth reports Q2 EPS (C$1.08) vs. (C$1.52) last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

T

AT&T

$39.15

-0.03 (-0.08%)

, VZ

Verizon

$59.41

0.07 (0.12%)

06:39
11/14/19
11/14
06:39
11/14/19
06:39
Downgrade
AT&T, Verizon, T-Mobile, Altice USA, Comcast, Dish, Sprint rating change  »

HSBC downgrades AT&T,…

T

AT&T

$39.15

-0.03 (-0.08%)

VZ

Verizon

$59.41

0.07 (0.12%)

TMUS

T-Mobile

$78.02

0.57 (0.74%)

ATUS

Altice USA

$26.84

0.33 (1.24%)

CMCSA

Comcast

$45.21

-0.02 (-0.04%)

DISH

Dish

$35.66

-0.37 (-1.03%)

S

Sprint

$6.07

0.215 (3.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 29

    Jan

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.